HB540: AN ACT relating to coverage for COVID-19 testing.
Legislative Summary
Create new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for polymerase chain reaction testing used to detect the COVID-19 virus; amend KRS 164.2871, 18A.225, 205.522, and 205.6485 to require self-insured employer group plans provided by the governing board of a state postsecondary education institution, the state employee health plan, Medicaid, and KCHIP to comply with the coverage requirement for polymerase chain reaction testing used to detect the COVID-19 virus; provide that various sections apply to health benefit plans issued or renewed on or after January 1, 2026; require the Department for Medicaid Services or the Cabinet for Health and Family Services to obtain federal approval, if necessary, and comply with notice requirements; EFFECTIVE, in part, January 1, 2026.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Status Information
Sponsors
Primary Sponsor
